News

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$354.6 million in 2025 and an impressive US$560.5 million ...
The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, ...
Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...
The Global Single Cell Analysis Market achieved a valuation of $4.90 Billion in 2024 and is anticipated to exceed $21.97 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 16.55% ...
Even if they like it, they won’t put a ring on it. There’s a reason why there are so many single ladies these days, according to experts. “There’s been a simple but profound shift in the ...
The company manufactures instruments, consumables, and software for whole-genome sequencing, exome sequencing, and single-cell transcriptomics. The Chromium platform developed by 10x Genomics is ...
Founded in 2012, 10x Genomics (NASDAQ ... and also consumables alongside the software. Its Chromium platform allows for single-cell analysis, while its Visium and Xenium enable spatial analysis.
In 2024, 10x Genomics worked to cement its status as “the single-cell analysis company,” making upgrades and additions to its portfolio of tools used by researchers in academia and industry to ...